We are live on ! Find out more
LCM

Legato Capital Management Portfolio holdings

AUM $1.21B
1-Year Est. Return 82.36%
This Fund
S&P 500
This Quarter Est. Return
+16.16%
1 Year Est. Return
+82.36%
3 Year Est. Return
+243.02%
5 Year Est. Return
+342.37%
10 Year Est. Return
+764.01%
AUM
$918M
AUM Growth
+$78.7M
Cap. Flow
-$9.19M
Cap. Flow %
-1%
Top 10 Hldgs %
12.06%
Holding
631
New
69
Increased
135
Reduced
112
Closed
73

Top Buys

Rank Stock Value
1
VC icon
Visteon
VC
+$2.62M
2
SYM icon
Symbotic
SYM
+$2.58M
3
CLMB icon
Climb Global Solutions
CLMB
+$2.58M
4
ADBE icon
Adobe
ADBE
+$1.81M
5
ROAD icon
Construction Partners
ROAD
+$1.77M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.62M
2
VRNA
Verona Pharma
VRNA
+$3.24M
3
SHO icon
Sunstone Hotel Investors
SHO
+$2.69M
4
BAC icon
Bank of America
BAC
+$2.21M
5
AMGN icon
Amgen
AMGN
+$2.19M

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Industrials 21.74%
3 Healthcare 15.84%
4 Consumer Discretionary 10.72%
5 Financials 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXS icon
201
Stereotaxis
STXS
$141M
$1.43M 0.16%
460,299
BBIO icon
202
BridgeBio Pharma
BBIO
$16.5B
$1.43M 0.16%
27,543
+6,472
+31% +$316K
GSBC icon
203
Great Southern Bancorp
GSBC
$878M
$1.43M 0.16%
23,342
+3,513
+18% +$214K
WAL icon
204
Western Alliance Bancorporation
WAL
$8.87B
$1.42M 0.16%
16,432
+6,832
+71% +$579K
HRMY icon
205
Harmony Biosciences
HRMY
$2.24B
$1.42M 0.15%
51,415
+19,504
+61% +$672K
EMR icon
206
Emerson Electric
EMR
$88.3B
$1.41M 0.15%
10,767
GSAT icon
207
Globalstar
GSAT
$10.8B
$1.41M 0.15%
+38,671
New +$1.11M
TXN icon
208
Texas Instruments
TXN
$261B
$1.41M 0.15%
7,652
ANIP icon
209
ANI Pharmaceuticals
ANIP
$1.78B
$1.4M 0.15%
15,280
-2,770
-15% -$226K
CXDO icon
210
Crexendo
CXDO
$222M
$1.4M 0.15%
215,207
SITE icon
211
SiteOne Landscape Supply
SITE
$4.53B
$1.39M 0.15%
10,767
+4,025
+60% +$546K
UVE icon
212
Universal Insurance Holdings
UVE
$1.23B
$1.38M 0.15%
52,358
NCLH icon
213
Norwegian Cruise Line
NCLH
$8.84B
$1.38M 0.15%
55,889
+11,479
+26% +$279K
ATEN icon
214
A10 Networks
ATEN
$1.95B
$1.37M 0.15%
75,635
LRN icon
215
Stride
LRN
$3.43B
$1.37M 0.15%
9,182
+1,299
+16% +$190K
TBBK icon
216
The Bancorp
TBBK
$2.84B
$1.37M 0.15%
+18,250
New +$1.27M
NDAQ icon
217
Nasdaq
NDAQ
$52.9B
$1.35M 0.15%
15,315
ABT icon
218
Abbott
ABT
$187B
$1.35M 0.15%
10,071
TEL icon
219
TE Connectivity
TEL
$62.6B
$1.34M 0.15%
6,122
BWAY
220
Brainsway
BWAY
$622M
$1.34M 0.15%
178,162
MXL icon
221
MaxLinear
MXL
$6.8B
$1.34M 0.15%
+83,282
New +$1.31M
OCUL icon
222
Ocular Therapeutix
OCUL
$2.02B
$1.32M 0.14%
112,820
SMP icon
223
Standard Motor Products
SMP
$911M
$1.31M 0.14%
32,176
-15,617
-33% -$572K
SRCE icon
224
1st Source
SRCE
$2.12B
$1.31M 0.14%
21,296
-5,162
-20% -$324K
APPF icon
225
AppFolio
APPF
$7.04B
$1.31M 0.14%
4,752

Similar funds

Legato Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Legato Capital Management held 631 positions worth $918M, up 9.4% from $839M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Legato Capital Management's Q3 2025 filing shows 69 new, 135 increased, 112 reduced and 73 closed positions. Its largest new stake was Visteon: 22,225 shares worth $2.66M. The largest sale was Broadcom, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Legato Capital Management's largest Q3 2025 buy was Visteon: 22,225 shares worth $2.66M.
  • Legato Capital Management added most to Construction Partners in Q3 2025, an estimated $1.77M increase.
  • Legato Capital Management's biggest Q3 2025 reduction was Broadcom, cutting an estimated $3.62M.
  • Legato Capital Management fully exited Verona Pharma in Q3 2025, selling an estimated $3.24M.
  • Legato Capital Management's ten largest holdings make up 12% of its $918M portfolio in Q3 2025.
  • Legato Capital Management opened 69 new positions and closed 73 in Q3 2025.
  • Legato Capital Management's portfolio value rose 9.4% quarter-over-quarter to $918M.

Based on Legato Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.